Julie Douville

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Top Venues

Nature medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alban Ziegler, Joanne Carroll, Jennifer M Bain, Tristan T Sands, Robert J Fee, David Uher, Cara H Kanner, Jacqueline Montes, Sarah Glass, Julie Douville, Laurence Mignon, Joseph G Gleeson, Stanley T Crooke, Wendy K Chung
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nature medicine (2024)
Alban Ziegler, Joanne Carroll, Jennifer M Bain, Tristan T Sands, Robert J Fee, David Uher, Cara H Kanner, Jacqueline Montes, Sarah Glass, Julie Douville, Laurence Mignon, Joseph G Gleeson, Stanley T Crooke, Wendy K Chung
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nature medicine (2024)
Alban Ziegler, Joanne Carroll, Jennifer M Bain, Tristan T Sands, Robert J Fee, David Uher, Cara H Kanner, Jacqueline Montes, Sarah Glass, Julie Douville, Laurence Mignon, Joseph G Gleeson, Stanley T Crooke, Wendy K Chung
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nature medicine (2024)
Joseph G Gleeson, C Frank Bennett, Jeffrey B Carroll, Tracy Cole, Julie Douville, Sarah Glass, Cedrik Tekendo-Ngongang, Amy C Williford, Stanley T Crooke
Personalized antisense oligonucleotides 'for free, for life' - the n-Lorem Foundation. Nature medicine (2023)
Scott V Dindot, Sarah Christian, William J Murphy, Allyson Berent, Jennifer Panagoulias, Annalise Schlafer, Johnathan Ballard, Kamelia Radeva, Ruth Robinson, Luke Myers, Thomas Jepp, Hillary Shaheen, Paul R Hillman, Kranti Konganti, Andrew E Hillhouse, Kevin R Bredemeyer, Lauren Black, Julie Douville, null null, null null
An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript. Science translational medicine 15 (688) (2023)
Scott V Dindot, Sarah Christian, William J Murphy, Allyson Berent, Jennifer Panagoulias, Annalise Schlafer, Johnathan Ballard, Kamelia Radeva, Ruth Robinson, Luke Myers, Thomas Jepp, Hillary Shaheen, Paul R Hillman, Kranti Konganti, Andrew E Hillhouse, Kevin R Bredemeyer, Lauren Black, Julie Douville, null null, null null
An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript. Science translational medicine 15 (688) (2023)